Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction

Research output: Contribution to journal › Article (Academic Journal) › peer-review

18 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{fc5ff887fb8a4332bd2672ea54ff8bda,

title = "Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction",

author = "Shahriar Behboudi",

year = "2004",

month = oct,

doi = "10.1016/j.vaccine.2004.04.029",

language = "English",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction

AU - Behboudi, Shahriar

PY - 2004/10

Y1 - 2004/10

UR - http://dx.doi.org/10.1016/j.vaccine.2004.04.029

U2 - 10.1016/j.vaccine.2004.04.029

DO - 10.1016/j.vaccine.2004.04.029

M3 - Article (Academic Journal)

SN - 0264-410X

JO - Vaccine

JF - Vaccine

ER -